JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY)

Previous Articles     Next Articles

Hypertonic saline solution of Pulmicort respules in post-operative recurrence of chronic sinusitis and nasal polyps after functional endoscopic sinus surgery

XU Li-na1,2, LUAN Jian-gang1, SONG Xi-cheng1, LI Yang3   

  1. Department of Otolaryngology & Head and Neck Surgery, 1. Yantai Yuhuangding Hospital Affiliated to Qingdao University, School of Medicine; 2. Fushan District Peoples Hospital of Yantai City; 3. Yantai Fushan District Disease Prevention and Control Center, Yantai 265500, Shandong, China
  • Online:2014-06-16 Published:2014-06-16

PDF (PC)

1281

Abstract: Objective    To evaluate the clinical effect of the 3% of hypertonic saline solution of Pulmicort respules in treatment of post-operative recurrence of chronic sinusitis and nasal polyps after functional endoscopic sinus surgery (FESS) accompanied with allergic rhinitis. Methods    Nasal lavage of this drug was performed one time per day lasting 3 to 5 weeks. Results    Of the 30 cases in the treatment group, 20 cases were cured, 8 cases were improved and 2 cases were invalid. Of the 20 cases in the control group, 4 cases were cured, 8 cases were improved, and 8 cases were invalid. Conclusion    3% hypertonic saline solution of Pulmicort respules is safe and effective in treatment of post-operative recurrence of chronic sinusitis and nasal polyps after FESS accompanied by allergic rhinitis.

CLC Number: 

  • R765
[1] ZHU Jiang, LIU Taixiang, JIANG Bing. Changes in conjunctival sac microbiota before and after endoscopic dacryocystorhinostomy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 13-20.
[2] LYU Qian, TANG Yuan, GU Zijun, SHI Sailei, LIU Ping, WAN Wenjin. Current status of benefit finding among patients with allergic rhinitis and its influence factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 21-28.
[3] GUO Rongchang, LIU Qinghang, WANG Hongzeng, SUN Shujun. Through the orbit with sinus huge foreign bodies embedded in the base of the skull: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 135-141.
[4] ZHANG Yongcai, ZHANG Jiang, LU Hui, XING Kexin, WU Jingfang, XUE Gang, LI Yanping, LIU Yanbin. Expression and significance of CXCL10 and IFN-γ in antrochoanal polyp [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 7-12.
[5] SU Riguge, LI Hua, WU Richaifu, HAN Eerdemutu, MENG Yongmei. Elucidation of the Mongolian medicine Huricha-6 mechanism in treating allergic rhinitis via network pharmacology and animal experiments [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 41-51.
[6] LI Xia, HOU Ran, WANG Liping. Bibliometric analysis based on Web of Science for nasal irrigation for nasal diseases in the last decade [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 52-60.
[7] LIU Jiaxin, JIANG Ye, SONG Daoliang. Endoscopic transnasal fenestration for maxillary bone cysts: a report of nine cases and a review of the literature [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 84-88.
[8] YAN Huijuan, XIAO Xuping, ZHONG Yu. Expression and clinical significance of IL-29 and TLR4 in eosinophil infiltrated nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 122-127.
[9] CHENG Xiqiao, QU Shenhong. Application and progress of three-dimensional-printing technology in rhinology [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 128-136.
[10] LIU Bo, XIAO Xuping, LI Yunqiu, ZHOU En, GUO Renbin. Bilateral ossification of the auricular cartilage: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 12-16.
[11] LI Dan, CHEN Tengyu, HUANG Yanfen, ZHOU Min, ZHOU Yixing, RUAN Yan, YAN Yajie. Research in the field of olfactory disorders in China—An analysis based on Citespace [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 40-48.
[12] LU Xiaoyan, WEN Shuxin. Advances in the treatment of congenital choanal atresia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 138-142.
[13] YUAN Chenyang, LIU Yan, FANG Zhensheng. Advances on the effect of OSAHS on pulmonary function in children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 143-148.
[14] Central retinal artery occlusion(CRAO)is the most common cause of acute vision loss. Thrombolysis is a more radical treatment than conservative treatment, including arterial thrombolysis and intravenous thrombolysis, as well as the combination therapy of thrombolysis and other therapies. Thrombolysis treatment can improve the visual acuity of CRAO patients, but because of its lack of randomized controlled trials, further clinical studies are needed to determine their efficacy and safety. Our review summarized the application progress of thrombolysis in recent ten years, further evaluated its safety and effectiveness, and provided an evidence for clinical application.. Application progress of thrombolysis in retinal artery occlusionYANG Ming Overview WEI Wenbin Guidance Beijing Tongren Hospital, Capital Medical University / Beijing Tongren Eye Center / Beijing key Laboratory of Intraocular Tumor Diagnosis and Treatment / Beijing Ophthalmology&Visual Sciences Key Lab / Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing 100730, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 5-10.
[15] ObjectiveTo discuss the early diagnosis and multidisciplinary diagnosis and treatment of neovascular glaucoma in ocular ischemic syndrome. MethodsThe medical records of a 54-year-old male patient with cerebral infarction who presented with right-eye vision loss that had persisted for a week were reviewed. After slit-lamp examination and fluorescence angiography, he was diagnosed with ocular ischemic syndrome(OIS)complicated by neovascular glaucoma in the right eye and treated with intravitreal injection of anti-VEGF drugs and panretinal photocoagulation. ResultsAfter three months of treatment, the right-eye iris neovascularization subsided, and the intraocular pressure was controlled within normal limits. ConclusionOcular ischemia is often missed or misdiagnosed by ophthalmologists, neurologists, cardiologists, and vascular surgeons due to its insidious onset and complex clinical manifestations. Therefore, the establishment of multidisciplinary diagnosis and treatment can improve the prognosis of OIS patients.. Neovascular glaucoma in ocular ischemic syndrome: a case report and literature reviewQIN Shuqi1, WANG Luping1, JIANG Bin2, WANG Yanling1 1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, China; 2. Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 53-55.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd